Weiss Asset Management LP[1 »

Xeris Pharmaceuticals shares owned by Weiss Asset Management LP[1

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Weiss Asset Management LP[1 from 13F filings

Historical chart of Weiss Asset Management LP[1 investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Weiss Asset Management LP[1 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Weiss Asset Management LP[1

Quarter filed Position value Share count Share price at filing
2025-09-30 $407k 50k 8.14
2025-06-30 $234k 50k 4.67
2025-03-31 $275k 50k 5.49
2024-12-31 $170k 50k 3.39
2024-09-30 $143k 50k 2.85
2024-06-30 $113k 50k 2.25
2024-03-31 $111k 50k 2.21

More positions owned by Weiss Asset Management LP[1

Strategy Cl A New (MSTR)
NVIDIA Corporation Put Option (NVDA)
Ishares Bitcoin Trust Etf Shs Ben Int Put Option (IBIT)
Ishares Ethereum Tr SHS Put Option (ETHA)
Interdigital Note 3.500% 6/0 (Principal)
Tesla Motors (TSLA)
Coinbase Global Com Cl A (COIN)
Strategy Note 0.625% 9/1 (Principal)
Super Micro Computer Note 3.500% 3/0 (Principal)
Ionis Pharmaceuticals Note 4/0 (Principal)
Theravance Biopharma (TBPH)
Sunrun Note 4.000% 3/0 (Principal)
Bridgebio Pharma Note 2.500% 3/1 (Principal)
Circle Internet Group Com Cl A (CRCL)
Broadcom Put Option (AVGO)

View all positions for Weiss Asset Management LP[1

Top funds holding Xeris Pharmaceuticals

BlackRock
Vanguard Group
D. E. Shaw & Co
Geode Capital Management
State Street Corporation
Morgan Stanley
Qube Research & Technologies
Nuveen
Driehaus Capital Management
Rosalind Advisors
Goldman Sachs Group
Parkman Healthcare Partners
UBS Group
Connor, Clark & Lunn Investment Management
Renaissance Technologies

View all funds holding Xeris Pharmaceuticals